证券代码：002788 证券简称：鹭燕医药 编号：2016-011 鹭燕医药股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------------|-----------------------|--------------------------------------------------------------| | | | | | | √ | 特定对象调研 □分析师会议 | | | □ | 媒体采访 □业绩说明会 | | 投资者关系 | □新闻发布会 □路演活动 | | | 活动类别 | □ 现场参观 | | | | □ | 其他（请文字说明其他活动内容） | | 参与单位名称 | | 淡水泉（北京）投资管理有限公司：周玖洲 | | 及人员姓名 | | | | 时间 | 2016 年 11 月 | 30 日下午 14:30-15:30 | | | | | | 地点 | 鹭燕医药会议室 | | | 上市公司 接待人员姓名 | | 副总经理兼董事会秘书雷鸣、证券事务代表阮翠婷 | | 投资者关系活 | 1 | 、两票制对福建省市场的影响。 | | 动 ...

Group 1: Market Position and Strategy - The company is one of the 11 enterprises responsible for the distribution of essential drugs in public medical institutions across Fujian Province, which is expected to enhance its market share due to increased market concentration from the new bidding process [2][3]. - The new bidding policy, effective from March 2016, limits the number of pharmaceutical companies to a maximum of 10 per region for drug distribution, compared to over 170 companies previously involved [3]. - The company aims to optimize resource allocation and enhance its distribution network across Fujian Province through improved coordination, business collaboration, and modern logistics [3]. Group 2: Third-Party Logistics Development - The company is the first in Fujian Province to obtain third-party logistics distribution qualifications, positioning itself advantageously in the market [4]. - It has begun to undertake logistics services for pharmaceutical and vaccine manufacturers, indicating a positive growth trend in this business segment [4]. Group 3: Retail Business Expansion - The retail module is a key business area, with the company having established 149 direct retail stores across 9 cities in Fujian Province by 2015 [4]. - Plans are in place to accelerate the establishment of 80 additional retail stores throughout Fujian Province, enhancing distribution and retail support for upstream suppliers [4]. Group 4: Impact of Policy Changes - The "Two-Invoice System" has been implemented in Fujian Province for several years, significantly contributing to the concentration of the pharmaceutical distribution market [5]. - The company plans to leverage the opportunities presented by the "Two-Invoice System" to expand its market presence outside Fujian Province when conditions are favorable [5]. Group 5: Compliance and Disclosure - The company adheres strictly to information disclosure regulations, ensuring that all disclosed information is accurate, complete, and timely, with no significant undisclosed information leaks [5].

编号：2017-002 证券代码：002788 证券简称：鹭燕医药 鹭燕医药股份有限公司 投资者关系活动记录表 | --- | --- | --- | |--------------|-------------------------|----------------------------------------------------------------| | | √ | 特定对象调研 □分析师会议 | | 投资者关系 | □ | 媒体采访 □业绩说明会 | | 活动类别 | □新闻发布会 □路演活动 | | | | □ 现场参观 | □其他（请文字说明其他活动内容） | | 参与单位名称 | 上海虢盛资本：王威 | | | 及人员姓名 | | | | 时间 | 2017 年 6 月 22 | 日上午 9:30-11:00 | | 地点 | 鹭燕医药会议室 | | | 上市公司 | | 副总经理兼董事会秘书雷鸣、证券事务代表阮翠婷 | | 接待人员姓名 | | | | 投资者关系活 | 1 | 、随着十标的开始及执行，公司市场占有份额是否有所提升？ | | 动主要内容介 | 2017 年福建省 | 1 ...

证券代码：002788 证券简称：鹭燕医药 编号：2017-001 鹭燕医药股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------------|-------------------------------|--------------------------------------------------------| | | √ | 特定对象调研 □分析师会议 | | 投资者关系 | □ | 媒体采访 □业绩说明会 | | 活动类别 | □新闻发布会 □路演活动 | | | | □ 现场参观 | □其他（请文字说明其他活动内容） | | | 西南证券：陈超 | | | 参与单位名称 | 平安证券：张熙 | | | 及人员姓名 | 淡水泉：周玖洲 红筹投资：邢云 | | | 时间 | 2017 年 5 月 12 | 日上午 9:00-10:30 | | 地点 | 鹭燕医药会议室 | | | 上市公司 接待人员姓名 | | 副总经理兼董事会秘书雷鸣、证券事务代表阮翠婷 | | 投资者关系活 | 1 | 、随着十标的开始及执行，公司市场占有份额是否有所提 ...

证券代码：002788 证券简称：鹭燕医药 编号：2016-009 鹭燕医药股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------|-------------------------------|--------------------------------------------------------------| | | | | | | √ 特定对象调研 □分析师会议 | | | | □ 媒体采访 □业绩说明会 | | | 投资者关系 | □新闻发布会 □路演活动 | | | 活动类别 | □ 现场参观 | | | | □ | 其他（请文字说明其他活动内容） | | 参与单位名称 | 兴银基金：王天洋 | | | 及人员姓名 | | | | | | | | 时间 | 2016 年 11 月 10 | 日下午 16:00-17:00 | | 地点 | 鹭燕医药会议室 | | | 上市公司 | | 副总经理兼董事会秘书雷鸣、证券事务代表阮翠婷 | | 接待人员姓名 | | | | 投资者关系活 | 1、两票制对福建省市场的影响。 | | | 动主要 ...

编号：2020-001 证券代码：002788 证券简称：鹭燕医药 鹭燕医药股份有限公司 投资者关系活动记录表 | --- | --- | --- | |--------------|----------------------------|----------------------------------------------------------| | | √ 特定对象调研 □分析师会议 | | | 投资者关系 | □ 媒体采访 □业绩说明会 | | | 活动类别 | □新闻发布会 □路演活动 | | | | □ 现场参观 | □其他（请文字说明其他活动内容） | | 参与单位名称 | 国元证券：刘慧敏、汤芬芬 | | | 及人员姓名 | | | | 时间 | 2020 年 5 月 8 | 日上午 10:00-11:30 | | 地点 | 鹭燕医药会议室 | | | 上市公司 | | 董事会秘书叶泉青、证券事务代表阮翠婷 | | 接待人员姓名 | | | | 投资者关系活 | | 一、介绍公司基本概况、业务布局。 | | 动主要内容介 | 二、沟通交流环节 | | | 绍 | 1 | 、公司近年来保 ...

证券代码：002788 证券简称：鹭燕医药 编号：2017-003 鹭燕医药股份有限公司 投资者关系活动记录表 | --- | --- | --- | |--------------|----------------------------|--------------------------------------------------------------| | | √ 特定对象调研 □分析师会议 | | | 投资者关系 | □ 媒体采访 □业绩说明会 | | | 活动类别 | □新闻发布会 □路演活动 | | | | □ 现场参观 | □其他（请文字说明其他活动内容） | | | 兴业证券：缪知函 | | | | 工银瑞信：李善欣 | | | 参与单位名称 | 民生信托：曾志兰 | | | 及人员姓名 | 厦门港务：肖生松 | | | | 国泰君安：秦瑶函 | | | | 创金合信基金：皮劲松 | | | 时间 | 2017 年 9 月 18 | 日下午 16:00-17:30 | | 地点 | 鹭燕医药会议室 | | | 上市公司 | | 副总经理兼董事会秘书雷鸣、证券事务代表阮翠婷 | | 接待 ...

Company Overview - Lu Yan Pharmaceutical Co., Ltd. has established a leading position in the pharmaceutical distribution market in Fujian Province, responding well to the province's medical reform policies [3] - The company primarily focuses on pure sales, maintaining stable gross margins, with retail pharmacy margins ranging between 20%-30% [4] Market Dynamics - The "Two Invoices System" was piloted in Fujian in 2009 and expanded nationwide by 2018, significantly impacting the competitive landscape of pharmaceutical distribution [3] - The market is expected to consolidate further, with regional and national leaders gaining more terminal resources, thereby squeezing the survival space of smaller distributors [3] Retail Expansion - The company plans to continue expanding its retail pharmacy network in Fujian, with a current total of 221 direct-operated stores, including over 70 DTP pharmacies [4] - Future retail expansion will focus on new store openings and maintaining a "wholesale-retail integration" business model [4] Geographic Expansion - Since 2017, the company has expanded its distribution network outside Fujian, focusing on Sichuan, Jiangxi, and Hainan, with 17 companies in Sichuan and 10 in Jiangxi [5] - Revenue growth in Sichuan and Jiangxi exceeded 50% in 2019, with plans to enhance competitiveness through resource integration and leveraging the "Two Invoices System" [5] Medical Device Sector - The medical device segment is a key growth area, with a 94.11% year-on-year increase in 2019, driven by the nationwide implementation of centralized procurement [6] - The company aims to further expand its market share in this sector [6] Technological Advancements - The company has established the Kangyuan Research Institute to explore the application of artificial intelligence in medical diagnostics, focusing on cardiovascular diseases [6] - Progress has been made in smart decoction and new business models in healthcare [6] Financial Strategies - The company has not engaged in refinancing since its listing and primarily relies on bank financing, with plans to increase direct financing efforts in the future [7] - The company is actively promoting its share placement, which has been delayed due to the pandemic [6] Logistics Development - The pharmaceutical logistics center in Fujian is well-equipped, with centers in Fuzhou and Putian completed, and a modern logistics center in Xiamen expected to be finished by June 2020 [7]

证券代码：002788 证券简称：鹭燕医药 编号：2018-001 鹭燕医药股份有限公司 投资者关系活动记录表 | --- | --- | --- | |--------------|----------------------------|----------------------------------------------| | | √ 特定对象调研 □分析师会议 | | | 投资者关系 | □ 媒体采访 □业绩说明会 | | | 活动类别 | □新闻发布会 □路演活动 | | | | □ 现场参观 | □其他（请文字说明其他活动内容） | | | 中信建投：程培 | | | | 富国基金：娄圣睿 | | | 参与单位名称 | 德邦证券：刁举鹏 | | | 及人员姓名 | 长信基金：张子乔 | | | | 广发证券：孙辰阳 | | | | 青榕资产：唐明 | | | | 金域投资：陈奕冰 | | | 时间 | 2018 年 1 月 11 | 日上午 9:00-10:30 | | 地点 | 鹭燕医药会议室 | | | 上市公司 | | 副总经理兼董事会秘书雷鸣、证券事务代表阮翠婷 | | 接待人员姓名 ...

证券代码：002788 证券简称：鹭燕医药 编号：2019-007 鹭燕医药股份有限公司 投资者关系活动记录表 | --- | --- | --- | |--------------|------------------------------|---------------------------------------------------------------------| | | √ 特定对象调研 □分析师会议 | | | 投资者关系 | □ 媒体采访 □业绩说明会 | | | 活动类别 | □新闻发布会 □路演活动 | | | | □ 现场参观 | □其他（请文字说明其他活动内容） | | | | 帮您调研、牛散大学堂：吴国平、方建华、陈辉、张永金、陈平 、王志芬、 | | 参与单位名称 | 廖友钰、黄起星 | | | | 厦门大学：熊永涛 | | | 及人员姓名 | 广东珀源：谭舒云 | | | | 广州国平才富信息科技：周亚军 | | | 时间 | 2019 年 11 月 26 | 日上午 10:00-12:00 | | 地点 | 鹭燕医药会议室 | | | 上市公司 | | 董事会秘书叶泉 ...